ARTIVION, INC.

By person

15 insiders · 64 transactions

26.2×

J. Patrick Mackin holds 26.2 times base salary in stock. $21.91M of shares against $835.15K in salary for 2025.

Salary from the company's own proxy. The shares are what J. Patrick Mackin last reported holding, valued at $24.97, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Mackin James P

President & CEO

—

$9.72M (9)

−$9.72M

877,275

1.80%

$21.91M

+24.3%

Stanton Marshall S.

SVP, Clinical & MD Affair

—

$3.43M (13) scheduled

−$3.43M

60,097

0.1233%

$1.50M

−29.6%

Holloway Jean F

SVP, General Counsel

—

$2.54M (13)

−$2.54M

184,118

0.3776%

$4.60M

+12.2%

Davis John E

Chief Commercial Officer

—

$1.75M (9)

−$1.75M

230,794

0.4734%

$5.76M

+37.4%

GREEN ANDREW M

SVP, Regulatory and Quality

—

$1.43M (6) scheduled

−$1.43M

40,160

0.0824%

$1.00M

−40.8%

Horton Amy

VP, Chief Accounting Officer

—

$870.06K (8)

−$870.06K

139,088

0.2853%

$3.47M

−0.6%

Berry Lance A

EVP, COO, CFO & Treasurer

—

$803.21K (5)

−$803.21K

210,112

0.4309%

$5.25M

+165.7%

Hoff Elizabeth A

Director

—

$189.41K (1)

−$189.41K

34,765

0.0713%

$868.08K

+38.7%

BEVEVINO DANIEL J

Director

—

157,637

0.3233%

$3.94M

+9.7%

ACKERMAN THOMAS F

Director

—

157,472

0.3230%

$3.93M

+9.7%

Salveson Jon W

Director

—

137,416

0.2818%

$3.43M

+11.3%

Bullock James

Director

—

76,223

0.1563%

$1.90M

+22.3%

Burbank Jeffrey H

Director

—

61,372

0.1259%

$1.53M

+29.3%

Borgstrom Marna P

Director

—

56,938

0.1168%

$1.42M

+33.1%

SEMEDO ANTHONY B.

Director

—

46,960

0.0963%

$1.17M

+39.9%

Individual transactions

Insider

Date

Role

Action

Price

Amount

GREEN ANDREW M

11 Jun 2026

SVP, Regulatory and Quality

Sold after exercise

30,000

$20.69

$620.82K

GREEN ANDREW M

11 Jun 2026

SVP, Regulatory and Quality

Sold after exercise

14,001

$20.71

$289.92K

Mackin James P

3 Dec 2025

President & CEO

Sold after exercise

30,921

$45.46

$1.41M

Mackin James P

2 Dec 2025

President & CEO

Sold after exercise

30,921

$45.56

$1.41M

Stanton Marshall S.

21 Nov 2025

SVP, Clinical & MD Affair

Sold after exercise

8,370

$45.35

$379.54K

Stanton Marshall S.

21 Nov 2025

SVP, Clinical & MD Affair

Sold after exercise

18,705

$44.91

$840.04K

Stanton Marshall S.

21 Nov 2025

SVP, Clinical & MD Affair

Sold after exercise

5,715

$45.35

$259.15K

Stanton Marshall S.

21 Nov 2025

SVP, Clinical & MD Affair

Sold after exercise

14,586

$44.92

$655.19K

Stanton Marshall S.

20 Nov 2025

SVP, Clinical & MD Affair

Sold after exercise

1,355

$44.28

$60.00K

Stanton Marshall S.

20 Nov 2025

SVP, Clinical & MD Affair

Sold after exercise

2,033

$44.32

$90.09K

Stanton Marshall S.

20 Nov 2025

SVP, Clinical & MD Affair

Sold after exercise

11,888

$44.14

$524.74K

Davis John E

17 Nov 2025

Chief Commercial Officer

Sold after exercise

6,394

$45.17

$288.82K

Holloway Jean F

17 Nov 2025

SVP, General Counsel

Sold after exercise

6,394

$45.17

$288.82K

Davis John E

14 Nov 2025

Chief Commercial Officer

Sold after exercise

6,393

$44.67

$285.58K

Holloway Jean F

14 Nov 2025

SVP, General Counsel

Sold after exercise

6,393

$45.00

$287.69K

Holloway Jean F

11 Nov 2025

SVP, General Counsel

Sold after exercise

10,000

$46.18

$461.80K

Show all 64 transactions →

By person

Individual transactions

What was left out